231 related articles for article (PubMed ID: 9306429)
1. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
[TBL] [Abstract][Full Text] [Related]
2. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of TNF-alpha effects on radiation efficacy in a human lung adenocarcinoma model.
Gridley DS; Andres ML; Garner C; Mao XW; Slater JM
Oncol Res; 1996; 8(12):485-95. PubMed ID: 9160352
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pGL1-TNF-alpha therapy in combination with radiation.
Li J; Andres ML; Fodor I; Nelson GA; Gridley DS
Oncol Res; 1998; 10(7):379-87. PubMed ID: 10063972
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model.
Gridley DS; Baer JR; Cao JD; Miller GM; Kim DW; Timiryasova TM; Fodor I; Slater JM
Int J Oncol; 2002 Aug; 21(2):251-9. PubMed ID: 12118318
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts.
Gridley DS; Hammond SN; Liwnicz BH
Anticancer Res; 1994; 14(3A):1107-12. PubMed ID: 8074459
[TBL] [Abstract][Full Text] [Related]
9. Immunohistological analysis of immune cell infiltration of a human colon tumor xenograft after treatment with Stealth liposome-encapsulated tumor necrosis factor-alpha and radiation.
Kim DW; Andres ML; Miller GM; Cao JD; Green LM; Seynhaeve AL; Ten Hagen TL; Gridley DS
Int J Oncol; 2002 Nov; 21(5):973-9. PubMed ID: 12370743
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation.
Mao XW; Green LM; Gridley DS
Oncology; 2001; 61(3):243-53. PubMed ID: 11574781
[TBL] [Abstract][Full Text] [Related]
11. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
13. A model using radiation and plasmid-mediated tumor necrosis factor-alpha gene therapy for treatment of glioblastomas.
Baher AG; Andres ML; Folz-Holbeck J; Cao JD; Gridley DS
Anticancer Res; 1999; 19(4B):2917-24. PubMed ID: 10652573
[TBL] [Abstract][Full Text] [Related]
14. Modulation of innate immunological factors by STEALTH liposome-encapsulated tumor necrosis factor-alpha in a colon tumor xenograft model.
Kim DW; Andres ML; Kajioka EH; Dutta-Roy R; Miller GM; Seynhaeve AL; ten Hagen TL; Gridley DS
Anticancer Res; 2002; 22(2A):777-88. PubMed ID: 12014650
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
[TBL] [Abstract][Full Text] [Related]
16. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta].
Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K
Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.
Gridley DS; Timiryasova TM; Miller GM; Andres ML; Dutta-Roy R; Bayeta EJ; Fodor I
Technol Cancer Res Treat; 2003 Feb; 2(1):41-50. PubMed ID: 12625753
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI].
Harada K; Yoshida J; Wakabayashi T; Sugita K; Kurisu K; Uozumi T; Zieroth BF; Takahashi M; Yamanaka T
No Shinkei Geka; 1995 Dec; 23(12):1069-74. PubMed ID: 8927213
[TBL] [Abstract][Full Text] [Related]
19. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
Pollack IF; Erff M; Ashkenazi A
Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
[TBL] [Abstract][Full Text] [Related]
20. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
Papadopoulou MV; Bloomer WD; Hollingshead MG
Anticancer Res; 2005; 25(3B):1865-9. PubMed ID: 16158918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
